Axela offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins and nucleic acids. Our suite of products are specifically targeted at biomarker testing and infectious disease research. They are commercialized through distributors in the Life Sciences and Clinical Research markets and specific applications are licensed to diagnostic or industry segment partners.
